Kim Kelderman, President Diagnostics & Genom at BIO-TECHNE Corp (TECH), sold 811 shares at $433.00 ($351K) on 2021-06-09, disclosed to the SEC on 2021-06-11.
Open-market sale of $351k TECH by President Diagnostics & Genom. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TECH | SELL | 2021-09-24 | $870K | — | Filing → |
| TECH | SELL | 2021-05-27 | $358K | — | Filing → |
| TECH | SELL | 2021-02-09 | $639K | — | Filing → |